Differential Expression of Senescence and Cell Death Factors in Non-Small Cell Lung and Colorectal Tumors Showing Telomere Attrition

被引:6
作者
Fernandez-Marcelo, Tamara [1 ,4 ]
Moran, Alberto [1 ,4 ]
de Juan, Carmen [1 ,4 ]
Pascua, Irene [1 ,4 ]
Head, Jacqueline [1 ,4 ]
Gomez, Ana [2 ,4 ]
Hernando, Florentino [2 ,4 ]
Lopez-Asenjo, Jose A. [5 ]
Hernandez, Susana [3 ,4 ]
Sanchez-Pernaute, Andres [2 ,4 ]
Torres, Antonio J. [2 ,4 ]
Benito, Manuel [1 ,4 ]
Iniesta, Pilar [1 ,4 ]
机构
[1] Univ Complutense, Dept Bioquim & Biol Mol 2, Fac Farm, ES-28040 Madrid, Spain
[2] Hosp Clin San Carlos, Serv Cirugia, Madrid, Spain
[3] Hosp Clin San Carlos, Serv Anat Patol, Madrid, Spain
[4] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain
[5] Hosp Principe Asturias, Serv Patol, Alcala De Henares, Spain
关键词
Telomeres; Telomerase; Senescence; Non-small cell lung cancer; Colorectal cancer; CHROMOSOMAL INSTABILITY; CANCER; LENGTH; CARCINOMA; PATHWAY; COLON; P53; PROGNOSIS; APOPTOSIS; DISEASE;
D O I
10.1159/000335678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The main aim of this work is to investigate the expression of factors related to senescence and cell death pathways in non-small cell lung cancers (NSCLCs) and colorectal cancers (CRCs) in relation to telomere status. Methods: We analyzed 158 tissue samples, 36 NSCLCs, 43 CRCs, and their corresponding control tissues obtained from patients submitted to surgery. Telomere function was evaluated by determining telomerase activity and telomere length. Expression of factors related to senescence, cell death pathways, transformation and tumorigenesis was investigated using arrays. Results were validated by real-time quantitative PCR. Results: Considering tumors with telomere shortening, expression for BNIP3, DAPK1, NDRG1, EGFR, and CDKN2A was significantly higher in NSCLC than in CRC, whereas TP53 was overexpressed in CRC with respect to NSCLC. Moreover, compared to nontumor samples, DAPK1, GADD45A, SHC1, and TP53 were downregulated in the group of NSCLCs with telomere shortening, and no significant differences were found in CRC. Conclusions: In NSCLC, the failure of pathways which involve factors such as DAPK1, GADD45A, SHC1, and TP53, in response to short telomeres, could promote tumor progression. In CRC, the viability of these pathways in response to short telomeres could contribute to limiting tumorigenesis.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 42 条
  • [11] Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer
    Frias, Cristina
    Garcia-Aranda, Cristina
    De Juan, Carmen
    Moran, Alberto
    Ortega, Paloma
    Gomez, Ana
    Hernando, Florentino
    Lopez-Asenjo, Jose-Antonio
    Torres, Antonio-Jose
    Benito, Manuel
    Iniesta, Pilar
    [J]. LUNG CANCER, 2008, 60 (03) : 416 - 425
  • [12] Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma - Prognostic indications
    Garcia-Aranda, C
    de Juan, C
    Diaz-Lopez, A
    Sanchez-Pernaute, A
    Torres, AJ
    Diaz-Rubio, E
    Balibrea, JL
    Benito, M
    Iniesta, P
    [J]. CANCER, 2006, 106 (03) : 541 - 551
  • [13] Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer
    González-Quevedo, R
    Iniesta, P
    Morán, A
    de Juan, C
    Sánchez-Pernaute, A
    Fernández, C
    Torres, A
    Díaz-Rubio, E
    Balibrea, JL
    Benito, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 254 - 262
  • [14] DAP kinase links the control of apoptosis to metastasis
    Inbal, B
    Cohen, O
    PolakCharcon, S
    Kopolovic, J
    Vadai, E
    Eisenbach, L
    Kimchi, A
    [J]. NATURE, 1997, 390 (6656) : 180 - 184
  • [15] p16INK4a as a second effector of the telomere damage pathway
    Jacobs, JJL
    de Lange, T
    [J]. CELL CYCLE, 2005, 4 (10) : 1364 - 1368
  • [16] Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
    Kyo, Satoru
    Takakura, Masahiro
    Fujiwara, Toshiyoshi
    Inoue, Masaki
    [J]. CANCER SCIENCE, 2008, 99 (08): : 1528 - 1538
  • [17] Heterogeneity in telomere length of human chromosomes
    Lansdorp, PM
    Verwoerd, NP
    vandeRijke, FM
    Dragowska, V
    Little, MT
    Dirks, RW
    Raap, AL
    Tanke, HJ
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (05) : 685 - 691
  • [18] Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
    Lantuejoul, S
    Soria, JC
    Moro-Sibilot, D
    Morat, L
    Veyrenc, S
    Lorimier, P
    Brichon, PY
    Sabatier, L
    Brambilla, C
    Brambilla, E
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1222 - 1229
  • [19] Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis
    Lantuejoul, Sylvie
    Raynaud, Christophe
    Salameire, Dimitri
    Gazzeri, Sylvie
    Moro-Sibilot, Denis
    Soria, Jean-Charles
    Brambilla, Christian
    Brambilla, Elizabeth
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (11) : 2979 - 2988
  • [20] Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15